Search

Displaying all 3 results
DrugBest match

Suzetrigine

go.drugbank.com/drugs/DB18927
ApprovedInvestigational

Suzetrigine is a NaV1.8 voltage-gated sodium channel blocker with analgesic properties NaV1.8 is abundantly expressed in peripheral sensory nerves to play a role in pain signal transmission, making it a desirable therapeutic target for treatment of pain. On January 30, 2025, suzetrigine was approved by the FDA as a ...

  1. Indication

    Acute, moderate Pain

    go.drugbank.com/conditions/DBCOND0112012
    Drugs: Floctafenine · Ketorolac · Oxycodone · Suzetrigine
  2. Indication

    Severe Acute Pain

    go.drugbank.com/conditions/DBCOND0021329
    Drugs: Celecoxib · Ketorolac · Oliceridine · Oxycodone · Sufentanil · Suzetrigine +1 more